A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing

Ji-Won Park1,2, Jung-Hee Kim3, Jang-Han Jung3

  • 1Department of Internal Medicine, Hallym University Sacred Heart Hospital of Hallym University Medical Center, 22, Gwanpyeong-ro 170 Beon-gil, Anyang-si 14068, Korea.

Insights

Multidrug-resistant organisms (MDROs) are increasingly causing pyogenic liver abscesses (PLAs). Inadequate initial antibiotic treatment is common in MDRO-PLA cases, necessitating updated empirical therapy and close patient monitoring.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Microbiology

Background:

  • Multidrug-resistant organisms (MDROs) pose a significant global health threat.
  • Pyogenic liver abscesses (PLAs) are serious infections with limited data on MDRO involvement.
  • Understanding MDRO-PLA epidemiology and risk factors is crucial for effective management.

Purpose of the Study:

  • To investigate the incidence, clinical characteristics, and outcomes of PLAs caused by MDROs.
  • To identify risk factors associated with MDRO-induced PLAs.
  • To evaluate factors predicting mortality in PLA patients.

Main Methods:

  • Retrospective study of 833 PLA patients (2008-2017).
  • Propensity score matching (PSM) for comparing MDRO and non-MDRO groups (1:3 ratio).
  • Analysis of clinical features, risk factors, and mortality predictors.

Main Results:

  • MDROs identified in 6.6% of PLA cases; extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae were most common.
  • PSM revealed prior hepatobiliary procedures, preadmission antibiotic exposure, and elevated alkaline phosphatase as PLA risk factors.
  • In-hospital mortality was 7.3%; ICU admission, inadequate initial antibiotics, and inotropic agent use predicted mortality.

Conclusions:

  • MDROs are an emerging cause of PLAs, with specific risk factors identified.
  • While MDROs did not directly increase mortality, inadequate initial antibiotic treatment was prevalent in MDRO-PLA patients.
  • Empirical antibiotic strategies for PLA should consider MDROs, and high-risk patients require vigilant monitoring.